Further promotion of "the JSH plan for the future" conscious of new normal after/with COVID-19: message from the new president of the Japanese Society of Hypertension.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Digital hypertension, implementation hypertension, and internationalization - 3 pillars of Japanese Society of Hypertension 2024-2026 advancing hypertension science from Japan to the world in the information network era.Hypertension research : official journal of the Japanese Society of Hypertension · 2025
   Article
2. Digital hypertension towards to the anticipation medicine.Hypertension research : official journal of the Japanese Society of Hypertension · 2023
   Review
3. Topics 2023 in Hypertension Research leading to guidelines in Asia.Hypertension research : official journal of the Japanese Society of Hypertension · 2023
   Article
4. Current situation of telemedicine research for cardiovascular risk in Japan.Hypertension research : official journal of the Japanese Society of Hypertension · 2023
   Review
5. The first software as medical device of evidence-based hypertension digital therapeutics for clinical practice.Hypertension research : official journal of the Japanese Society of Hypertension · 2022
   Review
6. Latest hypertension research to inform clinical practice in Asia.Hypertension research : official journal of the Japanese Society of Hypertension · 2022
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as